CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DEMarquee-fund ownership over time
This quarter's activity
New positions opened
Positions exited
None.
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Renaissance Technologies | Q3 2024(8Q snapshot) | 7Q | $1.86 | $3.39 | +82% |
| Citadel Advisors | Q3 2024(8Q snapshot) | 7Q | $2.51 | $3.39 | +35% |
| AQR Capital Management re-entered | Q3 2024(8Q snapshot) | 7Q | $2.51 | $3.39 | +35% |
| Millennium Management re-entered | Q3 2024(8Q snapshot) | 7Q | $2.51 | $3.39 | +35% |
| Point72 Asset Management re-entered | Q4 2024(8Q snapshot) | 6Q | $3.08 | $3.39 | +10% |
| D.E. Shaw | Q3 2025(8Q snapshot) | 3Q | $2.57 | $3.39 | +32% |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Two Sigma Investments | Q3 2024 | Q2 2025 | → $3.41 | +36% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at CLOVER HEALTH INVESTMENTS, CORP. /DE. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from May 28, 2026 — the most recent Form 4 on file — not from today.
- Form 40001971702-26-000010May 28, 2026
- Form 40001801170-26-000131May 19, 2026
- Form 40001801170-26-000130May 18, 2026
- Form 40001938197-26-000011May 13, 2026
- Form 40001801170-26-000123May 12, 2026
- Form 40001801170-26-000090Apr 21, 2026
- Form 40001938197-26-000008Apr 16, 2026
- Form 40001999086-26-000012Apr 16, 2026
- Form 40001838733-26-000012Apr 16, 2026
- Form 40001801170-26-000089Apr 16, 2026
- Form 40001839066-26-000015Apr 16, 2026
- Form 40001971702-26-000007Apr 16, 2026
- Form 40001839066-26-000014Apr 7, 2026
- Form 40001938197-26-000007Apr 3, 2026
- Form 40001839066-26-000012Apr 3, 2026
Fundamentals
XBRL · CLOVER HEALTH INVESTMENTS, CORP. /DEAnnual figures sourced directly from CLOVER HEALTH INVESTMENTS, CORP. /DE's 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for CLOVER HEALTH INVESTMENTS, CORP. /DE — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 8-KMaterial eventMay 18, 2026
- 10-QQuarterly reportMay 8, 2026
- 8-KMaterial eventMay 6, 2026
- DEF 14AProxy statementApr 28, 2026
- 8-KMaterial eventApr 1, 2026
- 8-K/A8-KMar 6, 2026
- 8-KMaterial eventMar 6, 2026
- 10-KAnnual reportFeb 27, 2026
- 8-KMaterial eventFeb 26, 2026
- 8-KMaterial eventJan 14, 2026
- 8-KMaterial eventDec 10, 2025
- 8-KMaterial eventNov 12, 2025
- 10-QQuarterly reportNov 7, 2025
- 8-KMaterial eventNov 4, 2025
- 8-KMaterial eventOct 31, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Millennium Management | Q2 2026 | open | $3.47 | $3.39 | -2% |
| Point72 Asset Management | Q2 2026 | open | $3.47 | $3.39 | -2% |
| D.E. Shaw | Q3 2025 | open | $2.57 | $3.39 | +32% |
| AQR Capital Management | Q2 2025 | open | $3.41 | $3.39 | -1% |
| Point72 Asset Management | Q4 2024 | Q2 2025 | $3.08 | $3.41 | +11% |
| Citadel Advisors | Q3 2024 | open | $2.51 | $3.39 | +35% |
| Two Sigma Investments | Q3 2024 | Q2 2025 | $2.51 | $3.41 | +36% |
| AQR Capital Management | Q3 2024 | Q4 2024 | $2.51 | $3.08 | +23% |
| Millennium Management | Q3 2024 | Q1 2026 | $2.51 | $2.04 | -19% |
| Renaissance Technologies | Q3 2024 | open | $1.86 | $3.39 | +82% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.